The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.
about
Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisHigh-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients.Total cholesterol level for assessing pancreatic insufficiency due to chronic pancreatitis.The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell CarcinomaPrognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapyA comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaExpansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection.A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinomaCirculating markers for prognosis of hepatocellular carcinoma.Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.The Glasgow Prognostic Score and its variants predict mortality in living donor but not in deceased donor liver transplantation for hepatocellular carcinoma: A double-center validation study.Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC.Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery.Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation.Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients.Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma.Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.A Liver Index and its Relationship to Indices of HCC AggressivenessEvaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma
P2860
Q26776504-38E15B68-D3D7-4CAE-AC34-5231B4F73BB7Q34168947-6D33C92D-1491-42DC-9C50-745275F31246Q34182162-AA459172-074C-481E-BFF1-1C3D49016282Q34506005-E30145AE-C7AC-4029-94B4-C4493C9C5AB8Q35073362-F788A08C-FAB5-46D9-9D42-51AE401CEC5FQ35161694-3994CA2F-52A6-4069-8F97-E4CFEC67E2E8Q35226677-22FC7157-158A-410E-B6F2-FA179B403795Q35781911-87F13357-9F27-4843-B7CF-5700AF1F49A2Q35965415-126C6EBF-BC41-465C-95F3-B15AC7C6E1DBQ36151682-495DB2C8-810A-4C1E-B230-66FC8D194021Q36194925-3B764AB4-F1C0-4F07-9249-9FEF4093C53CQ36241124-172C71FA-EF15-4959-9DE2-C672582BF872Q36335396-1864BAE7-1BC1-4AEC-9638-470682F0FCB2Q37465628-6E61C32F-66BA-4D6F-AA3A-1225D0E509AFQ37731958-5FD4E57D-40D3-4B11-8DD2-3E47BA9E4E31Q38103946-35A40A5B-EDD8-4C0F-BE66-7AA04DD3EE2FQ39204902-E6C96B01-C02F-40F3-B013-02BC8BE02F72Q39420185-049C266E-C8B6-4C58-A69A-44B9BC9A6629Q39468081-F4C8BEAE-B734-4118-9CF0-5D4A0506D7BCQ39960509-F9321C1B-55F9-45DE-BFF2-BDB6F7340932Q40061509-F1332738-16F8-49CF-B4E1-75569732F8EDQ40500922-FF39AD52-C542-4D44-AA0E-044859D0BCE2Q40833239-BCAB7D7B-8766-497E-8E90-70CEFFC21AD7Q48314131-104B4337-3F5A-499B-9A36-ACBD0CFEC388Q51708886-C8CB71FB-2829-4B3C-AF94-F361BA7F064EQ53505738-0F507B74-8255-4785-A8D3-121B29D7F164Q56963371-45CC92BE-652D-4B7A-B608-95C92F7EB2A2Q57154016-C70067F3-DA5F-42A8-B11E-03C599D397A7
P2860
The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@ast
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@en
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@nl
type
label
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@ast
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@en
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@nl
prefLabel
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@ast
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@en
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The Glasgow Prognostic Score, ...... with hepatocellular carcinoma.
@en
P2093
Akira Iwaku
Akiyoshi Kinoshita
Chisato Saeki
Hirokazu Nishino
Hiroshi Onoda
Hisao Tajiri
Kazuhiko Koike
Ken Tanaka
Masato Matsushima
Mutumi Oishi
P2860
P2888
P356
10.1186/1471-2407-13-52
P407
P577
2013-02-02T00:00:00Z
P5875
P6179
1039715157